MC
Michael N Chang
Director

Michael N Chang insider trades: Optimer Pharmaceuticals (OPTR) stock purchases

Director, Optimer Pharmaceuticals Last trade Dec 29, 2009 39 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2007
1
Company
last trade 2009

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Michael reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Dec 29, 2009OPTR↑ Buy$195K
Nov 25, 2009OPTR↑ Buy$173K
Jun 13, 2008OPTR↑ Buy$35K
May 15, 2008OPTR↑ Buy$15K
May 15, 2008OPTR↑ Buy$12K
Nov 15, 2007OPTR↑ Buy$6K
Nov 15, 2007OPTR↑ Buy$6K
Aug 9, 2007OPTR↑ Buy$246K
Aug 6, 2007OPTR↑ Buy$91K
Jul 16, 2007OPTR↑ Buy$99K
Feb 14, 2007OPTR↑ Buy$805K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Michael N Chang's insider trades

Michael N Chang is a director at Optimer Pharmaceuticals (OPTR). Since Feb 14, 2007, Michael has reported 11 open-market purchases worth $1.7M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), option exercises (9 filings), other transactions (7 filings), gifts (3 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPTR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.